Here are relevant reports on : veterinary-dermatology-drugs-market
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Pharmaceuticals Market by Product (Drugs, Vaccines, Medicatives feed additives), Animal Type (Production, Companion), Route of Administration (Oral, Parenteral), Distribution Channel (Veterinary Hospitals, Clinics), Indication (Infectious, Dermatology, Pain) and Region - Global Forecast to 2027
The global veterinary pharmaceuticals market size is projected to reach USD 39.0 billion by 2027 from USD 27.5 billion in 2022, at a CAGR of 7.5% during the forecast period. Market is driven by factors such as growing livestock population, rise in pet ownership, rising meat & diary consumption, incrementing number of infectious diseases among animals, mandatory animal vaccinations. On the other hand, rising threat of antibiotic resistance, poor veterinary healthcare infrastructure is expected to limit market growth to a certain extent in the coming years.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029
The global udder health market, valued at US$1.13 billion in 2023, stood at US$1.18 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$1.58 billion by the end of the period. The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Care Market Size by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Global Forecast to 2025
The global veterinary care market growth is primed to transition from USD 5.2 billion in 2018 to USD 23 billion by 2025, showcasing a strong CAGR of 5.7%. Key factors driving growth include increasing regulatory initiatives and rising demand for animal health products, particularly in regions like Asia and Latin America.
- Published: September 2020
- Price: $ 12000
- TOC Available:
-
COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025
The COVID-19 vaccines & drugs market is expected to grow from USD 2,273 million in 2022 to USD 1,401 million by 2025 at a compound annual growth rate (CAGR) of 14.9% during the forecast period.Key players in the COVID-19 vaccines market include Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), Janssen Pharmaceuticals, Inc. (Belgium) among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Global Ophthalmology Drugs & Devices Market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
- Published: May 2010
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
